Biotech Startups
9,847 companies tagged Biotech, with their investors and founders.
InstaDeep is an AI company founded in 2014 that develops machine learning solutions, partnering with organizations like Google DeepMind. The company maintains offices across London, Paris, Berlin, Tunis, Kigali, Cape Town, New York, and San Francisco.
3 investors
IntegriCulture is a Japanese cellular agriculture company developing cell-culture systems and production technology for cultured foods, along with OEM/ODM cosmetics and supplements and sales of cell-culture consumables and equipment. It applies its "CulNet"/cell-culture technology to help address protein supply and offers products across the food and cosmetics sectors.
3 investors
InterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions. Its technology targets venous disease conditions such as postthrombotic syndrome that current therapies fail to address.
3 investors
Invenio develops rapid on-site tissue imaging systems combined with AI to improve cancer patient care. The company serves pathologists and oncologists with real-time diagnostic tools for cancer detection.
3 investors
Inventage Lab develops microfluidic-based drug-delivery platform technologies for long-acting injectables, high-concentration biologics, and gene and nucleic-acid therapeutics, offering control over particle uniformity and release kinetics along with scale-up to GMP manufacturing. It serves biopharmaceutical partners across the drug formulation and delivery cycle, from R&D through commercial production.
3 investors
Inventia Life Science provides RASTRUM Workflow Paths, tools for generating reproducible 3D cell models for research and drug discovery. The platform offers flexible discovery workflows and predefined validated solutions for teams conducting biological research and assay development.
3 investors
Iridia develops Molecular Avatar Technology that embeds unalterable molecular identities and custom data (text, image, audio, or video) into physical products and materials such as paints, coatings, plastics, and liquids. The technology is aimed at brands seeking product authentication, traceability, and anti-counterfeiting without changing a product's appearance or function.
3 investors
IrisMed is an AI-powered software platform that automates insurance verification and patient cost estimation for optical practices, integrating with existing practice management systems. It helps dispensaries determine accurate patient out-of-pocket costs for lenses, coatings, and frames while identifying upsell opportunities.
3 investors
Iterion Therapeutics is a clinical-stage biopharmaceutical company developing cancer therapies targeting the Wnt/Ξ²-catenin pathway. Its lead candidate is in clinical trials for advanced hepatocellular carcinoma and other Wnt-driven tumors such as colorectal cancer.
3 investors
Iterum Therapeutics develops anti-infective compounds to treat infections caused by multi-drug resistant pathogens. The company's lead product, sulopenem (ORLYNVAH), has been approved by the FDA for treating uncomplicated urinary tract infections in adult women.
3 investors
Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors. The system is designed for nursing staff, pharmacists, IT departments, clinical engineers, and anesthesia professionals in healthcare facilities.
3 investors
IVIM Technology develops intravital microscopy systems, including confocal and two-photon microscopes for in vivo imaging of living organisms, and provides contract research organization (CRO) services for preclinical in vivo imaging. It serves academic and pharmaceutical researchers, with an R&D center in Daejeon.
3 investors
Jacobio is a biopharmaceutical company developing novel oncology therapeutics, focusing on next-generation antibody-conjugated drugs including ATDCs, ISACs, and AOCs to treat cancer patients.
3 investors
Jaguar Gene Therapy develops gene therapy treatments for severe genetic diseases, focusing on AAV-based platform therapies designed to deliver one-time, long-lasting treatments. The company serves patients with severe genetic diseases with significant unmet medical needs.
3 investors
Janux Therapeutics develops precision-engineered bispecific immunotherapies, including tumor-activated T cell engagers (TRACTr), designed to modulate T cells to treat cancer and autoimmune diseases. Its lead clinical program targets prostate cancer.
3 investors
JNPMEDI is a South Korean company that builds medical data platforms using blockchain and cloud technology, including a clinical trial data management solution. It serves clinical trial and healthcare clients, and in 2024 expanded into professional services applying digital technology across clients' business processes.
3 investors
Judo Bio develops oligonucleotide medicines, including ligand-siRNA conjugate drugs, delivered to the kidney for systemic and renal diseases using its STRIKE (Selectively Targeting RNA Into KidnEy) platform. The company applies RNA-based therapeutics that harness a natural endogenous mechanism for receptor-mediated uptake by specific kidney cell types to silence disease-modifying genes.
3 investors
A biopharmaceutical company developing CAR-T cell therapies for cancer treatment. The company produces Benastim (ηεΊε₯₯δ»θ΅ζ³¨ε°ζΆ²), a CAR-T therapeutic approved by China's National Medical Products Administration.
3 investors
A biotechnology company developing cancer therapies for patients with unmet medical needs. Its clinical pipeline includes the KTX-1001 and KTX-2001 programs.
3 investors
KAICO produces difficult-to-express proteins using silkworm technology for use as pharmaceuticals, diagnostic tools, and reagents. The company partners with pharmaceutical manufacturers to develop new drugs using its core platform for protein production in silkworms.
3 investors
3 investors
KalVista Pharmaceuticals is a global biopharmaceutical company that develops oral therapies for rare diseases, starting with hereditary angioedema (HAE). Its pipeline includes preclinical oral Factor XIIa inhibitors targeting HAE prophylaxis as well as thrombosis and inflammation.
3 investors
Karyopharm is a pharmaceutical company developing drugs based on its SINE (Selective Inhibitor of Nuclear Export) technology, with medicines targeting cancers including multiple myeloma and diffuse large B-cell lymphoma. It serves patients and healthcare providers in oncology.
3 investors
KBCols Sciences uses biotechnology to develop sustainable pigments and bioactive compounds for industrial applications across fashion, beauty, personal care, and food sectors by screening India's biodiversity.
3 investors